Changing from NAFLD to MASLD: Similar Prognosis of Patients with HCC Under Atezo/Bev treatment between NAFLD and MASLD

Clin Mol Hepatol. 2024 Jan 18. doi: 10.3350/cmh.2023.0557. Online ahead of print.NO ABSTRACTPMID:38246698 | DOI:10.3350/cmh.2023.0557

Source: Clinical and molecular hepatology - January 21, 2024 Category: Gastroenterology Authors: Hiroyuki Suzuki Shigeo Shimose Hideki Iwamoto Takashi Niizeki Takumi Kawaguchi Source Type: research